Sequence of the mRNA for a glutathione transferase Pi with a different substrate specificity in V79 Chinese hamster lung cells.

Gene

Department of Genetic and Cellular Toxicology, Wallenberg Laboratory, Stockholm University, Sweden.

Published: February 1994

The mRNA sequence for a glutathione transferase (GST) belonging to the Pi class has been determined. This was a first step towards elucidating, at the molecular level, why V79 Chinese hamster lung cells lack the capacity to conjugate the benzo[a]pyrene (BP) derivative BPDE, but nonetheless contain the GST pi gene, express GST pi mRNA and contain a protein that binds to antibodies directed against the human GST Pi enzyme. The sequencing strategy involved synthesis of a cDNA library, circularization of the GST pi cDNA for PCR amplification and subsequent DNA sequencing. The coding sequence for the GST Pi protein of V79 cells, designated CLOGSTP1, consisted of 627 bp coding for 209 amino acids (aa), corresponding to a 23-kDa protein. The cDNA sequence obtained demonstrated extensive homology to those from other species, especially rat and mouse, where this homology was 92 and 91%, respectively. Upon comparing the aa sequence predicted from CLOGSTP1 to those of rat, mouse, pig, cow and man, the most striking differences were found in aa positions 19, 39, 40, 110, 113 and 151. Consequently, the explanation for the lower capacity for GST Pi-catalyzed conjugation in V79 cells, as compared to other species, remains a matter of speculation, since none of these aa positions coincides with positions involved in the xenobiotic substrate-binding site of GST Pi from pig and human or of GST Mu from rat. The most likely candidates for causing the observed change in substrate specificity might be Lys110 and Glu113, which are the altered residues closest to this binding site and which might, thus, exclude BPDE as a substrate for the Chinese hamster enzyme.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0378-1119(94)90765-xDOI Listing

Publication Analysis

Top Keywords

chinese hamster
12
gst
9
glutathione transferase
8
substrate specificity
8
v79 chinese
8
hamster lung
8
lung cells
8
human gst
8
v79 cells
8
rat mouse
8

Similar Publications

Optimization of the intron sequences combined with the CMV promoter increases recombinant protein expression in CHO cells.

Sci Rep

January 2025

International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, Xinxiang, China.

To meet the requirements of the biopharmaceutical industry, improving the yield of recombination therapeutic protein (RTP) from Chinese hamster ovary (CHO) cells is necessary. The human cytomegalovirus (CMV) promoter is widely used for RTP expression in CHO cells. To further improve RTP production, we truncated the human CMV intron and further evaluated the effect of four synthetic introns, including ctEF-1α first, EF-1α first, chimeric, and β-globin introns combined with the CMV promoter on recombinant expression levels in transient and stably recombinant CHO cells.

View Article and Find Full Text PDF

Coronavirus epidemics have posed a serious threat to both human and animal health. To combat emerging infectious diseases caused by coronaviruses, various animal infection models have been developed and applied in research, including non-human primate models, ferret models, hamster models, mouse models, and others. Moreover, new approaches have been utilized to develop animal models that are more susceptible to infection.

View Article and Find Full Text PDF

Potential Interaction of Pinocembrin with Drug Transporters and Hepatic Drug-Metabolizing Enzymes.

Pharmaceuticals (Basel)

January 2025

Research Center of Transport Protein for Medical Innovation, Department of Physiology, Faculty of Science, Mahidol University, Ratchathewi, Bangkok 10400, Thailand.

: Pinocembrin is a promising drug candidate for treating ischemic stroke. The interaction of pinocembrin with drug transporters and drug-metabolizing enzymes is not fully revealed. The present study aims to evaluate the interaction potential of pinocembrin with cytochrome P450 (CYP450: CYP2B6, CYP2C9, and CYP2C19) and drug transporters including organic anion transporters (OAT1 and OAT3), organic cation transporters (OCT1 and OCT2), multidrug and toxin extrusion (MATE1 and MATE2, P-glycoprotein (P-gp), and breast cancer resistance protein (BCRP).

View Article and Find Full Text PDF

We present the first use of a bioengineered mammalian transposase system derived from Myotis lucifugus (bMLT) for integration of expression vectors into the CHO genome, focusing on GFP and trastuzumab production. Initially, CHO-K1 cells are transfected with a GFP reporter and varying amounts of bMLT DNA or mRNA. GFP expression is monitored over 17 weeks without selective pressure.

View Article and Find Full Text PDF

N-Glycosylation modulators for targeted manipulation of glycosylation for monoclonal antibodies.

Appl Microbiol Biotechnol

January 2025

School of Interdisciplinary Research, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, 110016, India.

Monoclonal antibodies are extensively used as biotherapeutics for treatment of a variety of diseases. Glycosylation of therapeutic antibodies is considered a critical quality attribute as it influences the effector function, circulatory half-life, immunogenicity, and eventually efficacy and patient safety. During upstream process development, media components play a significant role in determining the glycosylation profile.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!